MorphoSys: EU Conditionally Approves Minjuvi - Lenalidomide

MARTINSRIED (dpa-AFX) - The European Commission has granted conditional marketing authorization for Minjuvi or tafasitamab in combination with lenalidomide, followed by Minjuvi monotherapy, for

Related Keywords

Martinsried , Bayern , Germany , United States , , European Commission , Morphosys , Nconditionally , Pproves , Injuvi , Lenalidomide , Treat , Relapsed , Refractory , Dlbcl ,